← FDA Drug Approvals (Drugs@FDA)
OMEPRAZOLE AND SODIUM BICARBONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AJANTA PHARMA LTD · Approved 2016-07-27
Drug application
- FDA Application #
ANDA205545
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OMEPRAZOLE AND SODIUM BICARBONATE
- Generic name
- OMEPRAZOLE AND SODIUM BICARBONATE
- Active ingredients
- OMEPRAZOLE; SODIUM BICARBONATE
- Dosage form
- FOR SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AJANTA PHARMA LTD
- Manufacturer
- Ajanta Pharma USA Inc.
- First approval
- 2016-07-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown